PolyPid • PYPD
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Ms. Dikla Czaczkes Akselbrad$21.2M
Market Cap • 22/04/20242008
(há 16 anos)
2020
(4 years ago)
NASDAQ
Listagem
Petach Tikva
69
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
PYPDSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.